Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Enel to sell stakes in Enel Distribución Perú and Enel X Perú to CSGI for $2.9bn Enel’s subsidiary Enel Perú has agreed to divest its distribution, supply, and advanced energy services to China Southern… byPallavi MadhirajuApril 8, 2023